4.8 Article

Cullin 3 mediates SRC-3 ubiquitination and degradation to control the retinoic acid response

Publisher

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1102572108

Keywords

-

Funding

  1. Centre National de la Recherche Scientifique
  2. Institut National de la Sante et de la Recherche Medicale
  3. Agence Nationale pour la Recherche [ANR-05-BLAN-0390-02, ANR-09-BLAN-0297-01]
  4. Association pour la Recherche sur le Cancer [ARC-07-1-3169]
  5. Fondation pour la Recherche Medicale (FRM) [DEQ20090515423]
  6. Institut National du Cancer [INCa-PL09-194, PL07-96099]
  7. Ministere de l'Enseignement Superieur et de la Recherche
  8. FRM
  9. Lady TATA Memorial Trust
  10. Agence Nationale de la Recherche (ANR) [ANR-05-BLAN-0390, ANR-09-BLAN-0297] Funding Source: Agence Nationale de la Recherche (ANR)

Ask authors/readers for more resources

SRC-3 is an important coactivator of nuclear receptors including the retinoic acid (RA) receptor a. Most of SRC-3 functions are facilitated by changes in the posttranslational code of the protein that involves mainly phosphorylation and ubiquitination. We recently reported that SRC-3 is degraded by the proteasome in response to RA. Here, by using an RNAi E3-ubiquitin ligase entry screen, we identified CUL-3 and RBX1 as components of the E3 ubiquitin ligase involved in the RA-induced ubiquitination and subsequent degradation of SRC-3. We also show that the RA-induced ubiquitination of SRC-3 depends on its prior phosphorylation at serine 860 that promotes binding of the CUL-3-based E3 ligase in the nucleus. Finally, phosphorylation, ubiquitination, and degradation of SRC-3 cooperate to control the dynamics of transcription. In all, this process participates to the anti-proliferative effect of RA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available